[Expert consensus on the perioperative management of co-ablation system therapy of lung tumors].


Journal

Zhonghua nei ke za zhi
ISSN: 0578-1426
Titre abrégé: Zhonghua Nei Ke Za Zhi
Pays: China
ID NLM: 16210490R

Informations de publication

Date de publication:
01 Nov 2024
Historique:
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 31 10 2024
Statut: ppublish

Résumé

In order to improve the quality of clinical therapy and nursing care for patients with lung tumors undergoing Co-Ablation System and standardize perioperative management, the Committee of Ablation Therapy in oncology, Chinese Anti-Cancer Association, and the Expert committee on Ablation Therapy and the Committee of Interventional Perioperative, Interventional Physician Branch of Chinese Medical Doctor Association organized medical and nursing experts in China. Based on the clinical practice of Co-Ablation System therapy in China and relevant domestic literature, a perioperative management expert consensus was developed. The expert consensus included the key points of perioperative nursing care, prevention and intervention of complications, and discharge guidance for Co-Ablation System therapy of lung tumors, to provide reference for the standardization and development of clinical management for lung tumors. 为提高肺部肿瘤患者进行复合式冷热消融手术的临床治疗与护理质量,规范围手术期管理,由中国抗癌协会肿瘤消融治疗专业委员会、中国医师协会介入医师分会介入围手术学组组织国内相关领域的医疗和护理专家,以我国复合式冷热消融治疗的临床应用和经验为基础,结合国内相关文献,制订了围手术期管理专家共识。最终形成的共识包括了复合式冷热消融治疗肺部肿瘤围手术期管理要点、并发症的预防与干预、出院指导和随访管理等内容,可为接受复合式冷热消融治疗患者围手术期管理提供指导。.

Autres résumés

Type: Publisher (chi)
为提高肺部肿瘤患者进行复合式冷热消融手术的临床治疗与护理质量,规范围手术期管理,由中国抗癌协会肿瘤消融治疗专业委员会、中国医师协会介入医师分会介入围手术学组组织国内相关领域的医疗和护理专家,以我国复合式冷热消融治疗的临床应用和经验为基础,结合国内相关文献,制订了围手术期管理专家共识。最终形成的共识包括了复合式冷热消融治疗肺部肿瘤围手术期管理要点、并发症的预防与干预、出院指导和随访管理等内容,可为接受复合式冷热消融治疗患者围手术期管理提供指导。.

Identifiants

pubmed: 39482071
doi: 10.3760/cma.j.cn112138-20240620-00394
doi:

Types de publication

English Abstract Journal Article

Langues

chi

Sous-ensembles de citation

IM

Pagination

1078-1086

Subventions

Organisme : The Foundation of the National Key R&D Program-Application Demonstration Study of Domestic Innovative Tumor Composite Co-ablation System
ID : 2023YFC2414000

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH